The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.
Ready-to-use lyophilized RT-PCR Reagent;
Gold Standard for COVID-19 Diagnosis
A good environment is essential to sustainable development of human society. To minimize the impact on the environment, Wondfo focuses on energy conservationin on each link of supply chain, from procurement, manufacturing, storage, and distribution.
We encourage our suppliers to use more environment-friendly materials and processes to produce. We continuously improve our production process through innovation and introducing the latest technology to reduce waste and improve efficiency and we have specialists to ensure the discharge of industrial wastewater to meet the standards and regulations. And to reduce our carbon footprint, we have set up factories, branches, and subsidiaries at local markets.
What's more, Wondfo has a professional EHS team to formulate the company's general guideline and action principles on environmental, occupational health and safety protection.
Battles against Pandemic
During the SARS crisis in 2003, Wondfo launched the first SARS antigen test (Colloidal gold method) in China and got patented.
In 2009, the Influenza A H1N1 broke out, Wondfo’s H1N1 test kits were authorized to come to market and were comprehensively assessed as the best of its kind by the national government.
In 2013, with the outbreak of Novel Avian Influenza A(H7N9), Wondfo developed the first antigen test to human infection with subtype H7 avian influenza A viruses.
In 2016, Wondfo quickly developed Zika virus test kits to fight against the pandemic.
In 2020, Wondfo quickly responded to the outbreak of COVID-19 and specially set up an R&D team in the fight against the disease. In less than 2 months, Wondfo developed three kinds of COVID-19 antibody test kits that were quickly approved by NMPA certificate and CE marking.
Creating Opportunities
Wondfo brings people together and provides them with employment and education opportunities, helping them to live a more fulfilled life.
Wondfo has set up Wondfo University that provides fresh employees with information about company, including the culture, products, and policies, helping them to quickly fit into the company. Wondfo University supports employee learning by providing organized and diverse courses contributed by senior employees from various departments.
In addition, Wondfo has set up a foundation that encourages the further education of employees, equipping employees with the skills required for the changing global economy.
And, our commitment extends beyond hiring. We attaches great importance to cultivating the next generation of talented leaders. We actively cooperate with first-class universities and establish College-Enterprise cooperation projects in food engineering, medical and health. We provide students with internships, scholarships, and employment opportunities.
We are a best-in-class employer, providing access to a competitive wage, comprehensive insurance package, promising career prospect, leadership support, mentoring opportunities and more.
This website uses cookies. By continuing to browse or by clicking “Accept”, you agree to our use of cookies to enhance your experience.